Keywords: guilford, gliadel, reviewed, food, drug, administration, begun

Guilford's Gliadel Reviewed

Article | 08 April 1996

The US Food and Drug Administration has begun its review of Guilford Pharmaceutical's Gliadel wafer, a carmustine-based biodegradable implant for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Gliadel

Polifeprosan 20 with Carmustine

BiCNU

Carmustine

Go to drug listing